Starting January 2026, Medicare beneficiaries are saving real money at the pharmacy counter — in some cases more than $300 per month. Thanks to the Medicare Drug Price Negotiation Program, Medicare negotiated drug prices 2026 went into effect for the first time in history, covering 10 of the most widely used Part D medications. If you or a loved one takes any of these drugs, this article will explain exactly how much you can save and what steps to take right now.
What Are Medicare Negotiated Drug Prices in 2026?
The Inflation Reduction Act of 2022 gave Medicare the authority — for the first time ever — to directly negotiate drug prices with pharmaceutical manufacturers. Before this landmark law, Medicare was legally prohibited from negotiating. Private insurers and the Department of Veterans Affairs had that power; Medicare did not. That changed with the IRA, and in 2026, the results of those first negotiations are being felt by millions of seniors.
According to CMS (Centers for Medicare & Medicaid Services), 10 drugs have negotiated prices taking effect in 2026, with out-of-pocket costs for Medicare Part D enrollees dropping by an average of 50% compared to 2025 prices. Nearly 9 million Part D enrollees who use these 10 drugs are expected to save a combined $1.5 billion this year alone.
The 10 Negotiated Drugs: Your Savings at a Glance
According to an analysis by AARP, here are the major drugs with negotiated prices taking effect in 2026 and the estimated savings for Medicare Part D enrollees:
| Drug Name | Used To Treat | 2025 List Price (30-day) | 2026 Negotiated Price | % Savings |
|---|---|---|---|---|
| Januvia (sitagliptin) | Type 2 Diabetes | $527 | $113 | 79% |
| Eliquis (apixaban) | Blood clots, AFib | $521 | $231 | 56% |
| Xarelto (rivaroxaban) | Blood clots, AFib | ~$500 | ~$197 | ~61% |
| Entresto (sacubitril/valsartan) | Heart failure | ~$600 | ~$295 | ~51% |
| Enbrel (etanercept) | Rheumatoid arthritis | ~$7,000 | ~$2,355 | ~66% |
| Imbruvica (ibrutinib) | Blood cancers | ~$14,900 | ~$9,319 | ~37% |
| Stelara (ustekinumab) | Psoriasis, Crohn’s | ~$13,800 | ~$4,695 | ~66% |
| Fiasp/NovoLog (insulin aspart) | Diabetes | ~$495 | ~$119 | ~76% |
| Jardiance (empagliflozin) | Diabetes, heart failure | ~$550 | ~$197 | ~64% |
| Farxiga (dapagliflozin) | Diabetes, kidney disease | ~$550 | ~$179 | ~67% |
Medicare Negotiated Drug Prices 2026: Who Benefits Most?
The savings are most dramatic for seniors with diabetes, heart disease, blood clotting disorders, and autoimmune conditions — precisely the chronic conditions most common in people over 65. Let’s look at two specific scenarios:
Scenario 1: The Diabetic Senior on Januvia
Mary, 72, has been taking Januvia for her Type 2 diabetes for six years. In 2025, her 30-day supply cost $527 at list price. Starting January 2026, under the negotiated price, her cost drops to $113 — a savings of $414 per month, or nearly $5,000 per year. For a senior on a fixed income, this is transformative.
Scenario 2: The AFib Patient on Eliquis
Robert, 78, takes Eliquis daily to prevent strokes from atrial fibrillation. In 2025, his monthly cost was $521. In 2026, the negotiated price brings this down to approximately $231 per month — a savings of $290 monthly, or $3,480 per year. Many seniors who had been cutting pills or skipping doses due to cost can now afford to take their medication as prescribed.
How These Savings Work: Understanding the Mechanism
The negotiated prices are what CMS calls the “Maximum Fair Price” (MFP). These prices apply to Medicare Part D starting January 1, 2026. Here is how the savings flow through to you:
- CMS negotiates directly with the manufacturer to set a Maximum Fair Price based on the drug’s clinical effectiveness, unmet need, and R&D costs.
- Part D plans must apply these prices at the pharmacy counter beginning January 2026 for enrollees who purchase the negotiated drugs.
- Your out-of-pocket cost is calculated based on your plan’s cost-sharing — but the base price the plan pays has dropped dramatically, which flows through to your copay or coinsurance.
- The $2,000 Part D out-of-pocket cap (also new in 2026) works in tandem: once you’ve paid $2,000 out-of-pocket for Part D drugs in a year, your costs drop to $0 for the rest of the year.
What Seniors Must Do Right Now to Capture These Savings
- Check if your drug is on the list. Visit Medicare.gov and look up your medication in the drug price negotiation section.
- Review your Part D plan’s formulary. Call your plan and ask specifically about your drug’s cost under the 2026 negotiated price.
- Compare plans during Open Enrollment. If your plan doesn’t pass through these savings properly, you can switch during the next Open Enrollment (Oct 15 – Dec 7).
- Ask your pharmacist. At pickup, ask: “Is this the negotiated Medicare price for 2026?”
- Combine with Extra Help (LIS). If you qualify for the Low-Income Subsidy program, your savings could be even greater. Call 1-800-MEDICARE.
What’s Coming Next: More Drugs in 2027 and Beyond
The Medicare Drug Price Negotiation Program doesn’t stop at 10 drugs. CMS has announced that negotiated prices for 15 additional drugs will take effect in 2027, with projected annual savings of $8.5 to $12 billion for Part D enrollees. A third cycle — which for the first time includes Medicare Part B drugs administered in clinical settings — has already been announced for future years.
The Bottom Line
The debut of Medicare negotiated drug prices in 2026 marks a historic turning point for seniors who depend on life-saving medications. With savings averaging 50% on 10 major drugs, and nearly $1.5 billion expected to stay in beneficiaries’ pockets this year, this is one of the most impactful Medicare changes in decades. Review your coverage today, confirm the negotiated price is being applied, and take advantage of every dollar of savings available to you. You’ve earned it.
Sources
- CMS: Medicare Drug Price Negotiation Program 2026 Fact Sheet
- AARP: First Medicare-Negotiated Drug Prices Debut
- Medicare Rights Center: Negotiated Prices for Ten Drugs in 2026
Related Articles You May Find Helpful
- Medicare Part D’s $2,100 Drug Cap in 2026: How Seniors Save Thousands
- Medicare Part B Premium Hits $202.90 in 2026: What Every Senior Must Do
- Medicare Advantage 2026: Benefits Being Cut That Millions of Seniors Are Losing
- Free Medicare Preventive Screenings 2026: Complete Senior Guide
- 7 Government Benefits Seniors Are Missing in 2026
